Search Results - "Proskorovsky, I."

Cost‐effectiveness analysis of empagliflozin treatment in people with Type 2 diabetes and established cardiovascular disease in the EMPA‐REG OUTCOME trial by Kansal, A., Reifsnider, O. S., Proskorovsky, I., Zheng, Y., Pfarr, E., George, J. T., Kandaswamy, P., Ruffolo, A.

“…Aim In the EMPA‐REG OUTCOME trial, empagliflozin therapy reduced cardiovascular death by 38% compared with placebo when added to standard of care. Using the…”
Get full text

Mean overall survival gain with aflibercept plus FOLFIRI vs placebo plus FOLFIRI in patients with previously treated metastatic colorectal cancer by Joulain, F, Proskorovsky, I, Allegra, C, Tabernero, J, Hoyle, M, Iqbal, S U, Van Cutsem, E

“…Background: Mean survival in cancer trials can be estimated with statistical techniques to extrapolate study survival curves. This methodology was applied to…”
Get full text

Comparison of overall survival of lisocabtagene maraleucel (liso‐cel) versus standard of care (SOC) adjusting for crossover in second‐line (2L) R/R large B‐cell lymphoma by Morschhauser, F., Ghesquieres, H., Kamdar, M., Liu, F. F., Chandler, C., Crotta, A., Klijn, S. L., Elsada, A., Previtali, A., Chaillol, I., Proskorovsky, I., Schmitz, N., Gisselbrecht, C., Abramson, J. S.

Get full text

Quantifying the impact of progression on survival in oncology: An application of statistical modeling framework to measure the impact of events on subsequent risks by Ishak, K.J, Proskorovsky, I

Get full text

MODELING CARDIOVASCULAR OUTCOMES OF TREATMENT WITH EMPAGLIFLOZIN IN TYPE 2 DIABETES BASED ON HARD OUTCOMES DATA by Kansal, A, Zheng, Y, Proskorovsky, I, Krotneva, S, Kandaswamy, P, Ruffolo, A

Get full text

Simulated Treatment Comparisons – An Alternative Approach to Indirect Comparison When Standard Methods Are Not Feasible or Appropriate by Ishak, K.J, Proskorovsky, I, Benedict, A, Chen, C

Get full text

Considerations In The Appplication Of Novel Statistical Methods For Crossover Adjustment In Trials Of Cancer Treatments by Ishak, K.J, Proskorovsky, I, Korytowsky, B, Sandin, R

Get full text

Time Savings with Once-Monthly C.E.R.A.: A Time and Motion Study Conducted in 13 Hemodialysis Centres in Italy by De Cock, E, Kritikou, P, Proskorovsky, I, Tomic, R

Get full text

PND55 Multiple Sclerosis Impact Scale (MSIS-29): Its Validity and Responsiveness in Clinical Trial-Based Subjects by Guo, S, Proskorovsky, I, Phillips, G.A

Get full text

Impact of peginterferon beta-1a and disease factors on quality of life in multiple sclerosis by Newsome, S.D, Guo, S, Altincatal, A, Proskorovsky, I, Kinter, E, Phillips, G, You, X, Sabatella, G

“…Abstract Background The Phase III ADVANCE study has shown clinical benefits for peginterferon beta-1a 125 µg dosed every 2 weeks versus placebo at 1 year in…”
Get full text

Handling Variability in Time Endpoints in Multi-Centre Time and Motion (T&M) Studies: A Case Study of Erythropoiesis-Stimulating Agents for Anaemia Management in 13 Centres in Italy by Kritikou, P, De Cock, E, Proskorovsky, I, Payne, K.A, Tomic, R

Get full text

PRM57 Developing BASDAI and BASFI Predictive Equations From Clinical Trial Data of Golimumab for Severe, Active Ankylosing Spondylitis in Adults by Chaudhary, M.A, Hsu, B, Muszbek, N, Proskorovsky, I, Farrell, J

Get full text

PCN8 Axitinib (AXI) and Best Supportive Care (BSC) in the Treatment of Sunitinib-Refractory Patients With Metastatic Renal Cell Carcinoma (mRCC): Results of a Simulated Treatment Comparison (STC) Analyses by Proskorovsky, I, Benedict, A, Larkin, J.M.G, Sandin, R, Chen, C

Get full text

Smoking, smoking cessation and smoking relapse patterns: a web-based survey of current and former smokers in the US by Yeomans, K, Payne, K A, Marton, J P, Merikle, E P, Proskorovsky, I, Zou, K H, Li, Q, Willke, R J

“…The aim of this study was to characterise the natural course of smoking cessation behaviour in a web-based survey of current and former cigarette smokers (CS…”
Get more information

Predicting the long-term clinical effectiveness of daclizumab in relapsing-remitting multiple sclerosis: A new modeling framework using discrete event simulation by Guo, S, Hernandez, L, Saint-Laurent Thibault, C, Proskorovsky, I, Phillips, G.A

Get full text

MSR25 Uncertain About Uncertainty in Matching-Adjusted Indirect Comparisons (MAIC)? A Simulation Study to Compare Methods for Variance Estimation by Chandler, C., Proskorovsky, I.

Get full text

MSR78 Use of External Control Data to Adjust for Treatment Switching in Cost-Effectiveness Analyses: Lisocabtagene Maraleucel (Liso-Cel) Versus Standard of Care (SOC) in Second-Line Relapsed or Refractory Large B-Cell Lymphoma by Chandler, C., Liu, F.F., Klijn, S., Elsada, A., Proskorovsky, I.

Get full text

EE531 Evidence Generation Planning for and Economic Modeling of Rare Progressive Pediatric Diseases: Challenges and Prospective Solutions by Shaul, A., Sorensen, S., Proskorovsky, I., Ward, A.

Get full text

POSA308 A Comparison of STC and Maic Under Misspecification of the Treatment Effect and Effect-Modifier Relationship by Ishak, KJ, Kapetanakis, V, Proskorovsky, I, Fahrbach, K

Get full text

400P Impact of regorafenib dose optimization on comparative outcomes in the treatment of relapsed/refractory metastatic colorectal cancer (mCRC) by Burnett, H., Proskorovsky, I., Yoon, S.S., Wang, Y., Ostojic, H., Gaianu, L., Su, Y.

Get full text